HemaSphere

​​​​​​​​​​​​​​​​​​​About the Journal

AIMS & SCOPE

HemaSphere publishes results of highly relevant basic, translational, and clinical research in hematology. We are especially looking for strong studies reporting novel findings that are of high impact to the field of hematology.

Review articles, guideline articles, and controversy articles provide clear overviews and discussions of new developments as well as recommendations for patient care.

HemaSphere is the premier hematology information resource, which is covered by the HemaTopics section in the journal. This section provides insightful discussions on all aspects related to hematology, including summaries of important articles, reports of new therapies, discussions on European policy, and other hematology news items.

HemaSphere is an open access journal, powered by the European Hematology Association, and dedicated to supporting hematology patient care, research, and education worldwide.

IMPACT FACTOR & CITATION METRICS

HemaSphere is proud to have a 2021 Journal Impact Factor (JIF) of 8.3 (source: Journal Citation Reports, Clarivate).

INDEXING​

• SCIENCE CITATION INDEX EXPANDED (SCIE) - Hematology
• CC/CLINICAL MEDICINE - Hematology

PUBLICATION & EDITORIAL STAFF CONTACTS

Tarryn Greenberg
[email protected]

Editorial Manager, European Hematology Association
Jessica Mastrodomenico
[email protected]